HRAS and cancer: ISIS-2503, a 20-mer ASO that hybridizes to the 5′-untranslated region of human H-Ras mRNA and inhibits H-Ras expression, was developed as a potential treatment for cancer, particularly cancers with abnormalities of Ras function [15].